期刊
MEDICINAL RESEARCH REVIEWS
卷 38, 期 3, 页码 829-869出版社
WILEY
DOI: 10.1002/med.21479
关键词
antisense oligonucleotides; chemical modifications; gene-based therapeutics; gene delivery; nucleic acid drugs; precision medicine; siRNA
资金
- National Natural Science Foundation of China [21672015, 21372018, 21422201]
- Ministry of Science and Technology of PRC National Major Scientific and Technological Special Project for Significant New Drugs Development [2017ZX09303013]
Gene-based therapy is one of essential therapeutic strategies for precision medicine through targeting specific genes in specific cells of target tissues. However, there still exist many problems that need to be solved, such as safety, stability, selectivity, delivery, as well as immunity. Currently, the key challenges of gene-based therapy for clinical potential applications are the safe and effective nucleic acid drugs as well as their safe and efficient gene delivery systems. In this review, we first focus on current nucleic acid drugs and their formulation in clinical trials and on the market, including antisense oligonucleotide, siRNA, aptamer, and plasmid nucleic acid drugs. Subsequently, we summarize different chemical modifications of nucleic acid drugs as well as their delivery systems for gene-based therapeutics in vivo based on nucleic acid chemistry and nanotechnology methods.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据